URS
ADPT icon

Utah Retirement Systems’s Adaptive Biotechnologies ADPT Stock Holding History

Utah Retirement Systems’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,600
Closed -$229K – 987
2021
Q2 		$229K Buy
+5,600
New +$218K ﹤0.01% 964
2021
Q1 		– Sell
-3,900
Closed -$231K – 954
2020
Q4 		$231K Buy
+3,900
New +$201K ﹤0.01% 889

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Utah Retirement Systems's ADPT Position: Q3 2021 in Review

Utah Retirement Systems sold out of Adaptive Biotechnologies (ADPT) in Q3 2021, closing a stake of 5,600 shares — an estimated $229K sold.

Utah Retirement Systems first reported a position in ADPT in Q4 2020 and held it in 2 quarters. The position peaked at $231K in Q4 2020. 219 funds tracked by Wall St. Rank hold ADPT as of Q3 2021.

  • Utah Retirement Systems reported no remaining Adaptive Biotechnologies position as of Q3 2021 after selling out during the quarter.
  • Utah Retirement Systems sold 5,600 Adaptive Biotechnologies shares in Q3 2021, an estimated $229K.
  • Utah Retirement Systems first reported a position in Adaptive Biotechnologies in Q4 2020 and held it in 2 quarters.
  • Utah Retirement Systems's Adaptive Biotechnologies position peaked at $231K in Q4 2020.
  • 219 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2021.

Based on Utah Retirement Systems's 13F filing for Q3 2021, filed 16 Nov 2021.